跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,009 条关于
“NMDA receptor GluN2B subunit”
全部
13,009
临床试验
6,136
药物
1,488
机构
32
资讯
5,353
4个月前
GRIN Therapeutics Expands Phase 3 Beeline Trial to Europe for Rare Neurodevelopmental Disorder Treatment
去年
Seyltx Advances Chronic Cough Pipeline with Optimized Ifenprodil Dosing and Strategic NeurOp Partnership
去年
GRIN Therapeutics Initiates Radiprodil Trial for Seizures in TSC and FCD
去年
Novel NMDA Receptor Modulator Onfasprodil Shows Rapid Antidepressant Effects with Reduced Side Effects in Phase 2 Trial
去年
AXS-05, a Novel NMDA Receptor Antagonist, Shows Promise for Agitation in Alzheimer's Disease
3个月前
SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy
去年
IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression
去年
GRIN Therapeutics Secures $140M Series D and Global Partnership with Angelini Pharma for Radiprodil Development
去年
NMDA Receptor Research Reveals Novel Mechanism for Brain Stabilization and Potential Depression Treatments
2年前
Radiprodil Shows Promise in Reducing Seizure Frequency in GRIN-Related Neurodevelopmental Disorder
第 1 页，共 536 页
上一页
下一页
